» Articles » PMID: 23096711

Lysophosphatidic Acid Promotes Cell Migration Through STIM1- and Orai1-mediated Ca2+(i) Mobilization and NFAT2 Activation

Overview
Publisher Elsevier
Specialty Dermatology
Date 2012 Oct 26
PMID 23096711
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Lysophosphatidic acid (LPA) enhances cell migration and promotes wound healing in vivo, but the intracellular signaling pathways regulating these processes remain incompletely understood. Here we investigated the involvement of agonist-induced Ca(2+) entry and STIM1 and Orai1 proteins in regulating nuclear factor of activated T cell (NFAT) signaling and LPA-induced keratinocyte cell motility. As monitored by Fluo-4 imaging, stimulation with 10 μM LPA in 60 μM Ca(2+)(o) evoked Ca(2+)(i) transients owing to store release, whereas addition of LPA in physiological 1.2 mM Ca(2+)(o) triggered store release coupled to extracellular Ca(2+) entry. Store-operated Ca(2+) entry (SOCE) was blocked by the SOCE inhibitor diethylstilbestrol (DES), STIM1 silencing using RNA interference (RNAi), and expression of dominant/negative Orai1(R91W). LPA induced significant NFAT activation as monitored by nuclear translocation of green fluorescent protein-tagged NFAT2 and a luciferase reporter assay, which was impaired by DES, expression of Orai1(R91W), and inhibition of calcineurin using cyclosporin A (CsA). By using chemotactic migration assays, LPA-induced cell motility was significantly impaired by STIM1, CsA, and NFAT2 knockdown using RNAi. These data indicate that in conditions relevant to epidermal wound healing, LPA induces SOCE and NFAT activation through Orai1 channels and promotes cell migration through a calcineurin/NFAT2-dependent pathway.

Citing Articles

MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development.

Robert A, Crottes D, Bourgeais J, Gueguen N, Chevrollier A, Dumas J PLoS Biol. 2024; 22(10):e3002854.

PMID: 39466877 PMC: 11542858. DOI: 10.1371/journal.pbio.3002854.


Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.

Torres R, Turner J, DAntonio M, Pelanda R, Kremer K Immunol Rev. 2023; 317(1):203-222.

PMID: 37096808 PMC: 10523933. DOI: 10.1111/imr.13208.


Similarities and Differences between the Orai1 Variants: Orai1α and Orai1β.

Jardin I, Berna-Erro A, Nieto-Felipe J, Macias A, Sanchez-Collado J, Lopez J Int J Mol Sci. 2022; 23(23).

PMID: 36498894 PMC: 9735889. DOI: 10.3390/ijms232314568.


Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer.

Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Nishida M Int J Mol Sci. 2022; 23(4).

PMID: 35216080 PMC: 8877950. DOI: 10.3390/ijms23041967.


Transient Receptor Potential Ankyrin 1 (TRPA1)-An Inflammation-Induced Factor in Human HaCaT Keratinocytes.

Luostarinen S, Hamalainen M, Moilanen E Int J Mol Sci. 2021; 22(7).

PMID: 33805042 PMC: 8037497. DOI: 10.3390/ijms22073322.


References
1.
Frischauf I, Schindl R, Derler I, Bergsmann J, Fahrner M, Romanin C . The STIM/Orai coupling machinery. Channels (Austin). 2008; 2(4):261-8. DOI: 10.4161/chan.2.4.6705. View

2.
Jauliac S, Lopez-Rodriguez C, Shaw L, Brown L, Rao A, Toker A . The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002; 4(7):540-4. DOI: 10.1038/ncb816. View

3.
Sauer B, Vogler R, Zimmermann K, Fujii M, Anzano M, Schafer-Korting M . Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis. J Invest Dermatol. 2004; 123(5):840-9. DOI: 10.1111/j.0022-202X.2004.23458.x. View

4.
Santini M, Talora C, Seki T, Bolgan L, Dotto G . Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci U S A. 2001; 98(17):9575-80. PMC: 55494. DOI: 10.1073/pnas.161299698. View

5.
Baker D, Morrison P, Miller B, Riely C, Tolley B, Westermann A . Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. 2002; 287(23):3081-2. DOI: 10.1001/jama.287.23.3081. View